Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312076051> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4312076051 endingPage "06" @default.
- W4312076051 startingPage "01" @default.
- W4312076051 abstract "Ticagrelor is a BCS class IV drug that inhibits platelet action by reversibly binding to the P2Y12 receptor. One of the major challenges faced by the class IV (low solubility, low permeability) drug is the lower dissolution rate leading to low bioavailability. The bioavailability of the marketed formulation of ticagrelor is approximately 36%. Researchers have come up with various techniques to improve the BCS class II and IV drug formulations as an integral part of the development of the pharmaceutical sciences. An increase in solubility can be achieved by various methods such as Salt formation, Complexation, Micronization, Solid Dispersion, altering the pH, Co-solvency, co-crystals, polymeric micelles, etc. A highly efficacious technique is converting a crystalline drug to its amorphous form. An extensive literature search was conducted using various databases like science direct, Taylor and Francis, Springer to extract relevant articles. Keywords like “Ticagrelor”, “low permeability”, “P2Y12 receptor inhibitor” were used for the literature search. Relevant articles were screened and referred for further study. This article discusses the techniques employed to increase the solubility of ticagrelor, thus highlighting the research conducted and reported. The increase in bioavailability of ticagrelor could be seen when formulated as nanoparticles, co-crystals, ticagrelor loaded self-micro emulsifying and nano emulsifying drug delivery system, solid dispersion, etc. the conversion of the crystalline drug into amorphous drug is a highly recommended approach to increase the solubility of ticagrelor which can be seen in cases of co-crystals and solid dispersion formulation." @default.
- W4312076051 created "2023-01-04" @default.
- W4312076051 creator A5000186127 @default.
- W4312076051 creator A5030133655 @default.
- W4312076051 creator A5048747823 @default.
- W4312076051 creator A5067667984 @default.
- W4312076051 date "2022-12-20" @default.
- W4312076051 modified "2023-10-14" @default.
- W4312076051 title "A Review on Different Solubility Enhancement Techniques of Ticagrelor" @default.
- W4312076051 doi "https://doi.org/10.5530/223097131574" @default.
- W4312076051 hasPublicationYear "2022" @default.
- W4312076051 type Work @default.
- W4312076051 citedByCount "0" @default.
- W4312076051 crossrefType "journal-article" @default.
- W4312076051 hasAuthorship W4312076051A5000186127 @default.
- W4312076051 hasAuthorship W4312076051A5030133655 @default.
- W4312076051 hasAuthorship W4312076051A5048747823 @default.
- W4312076051 hasAuthorship W4312076051A5067667984 @default.
- W4312076051 hasBestOaLocation W43120760511 @default.
- W4312076051 hasConcept C147789679 @default.
- W4312076051 hasConcept C155574463 @default.
- W4312076051 hasConcept C171250308 @default.
- W4312076051 hasConcept C178790620 @default.
- W4312076051 hasConcept C181389837 @default.
- W4312076051 hasConcept C185592680 @default.
- W4312076051 hasConcept C187530423 @default.
- W4312076051 hasConcept C192562407 @default.
- W4312076051 hasConcept C2777628954 @default.
- W4312076051 hasConcept C2777849778 @default.
- W4312076051 hasConcept C2779820397 @default.
- W4312076051 hasConcept C2780890252 @default.
- W4312076051 hasConcept C49059817 @default.
- W4312076051 hasConcept C55493867 @default.
- W4312076051 hasConcept C56052488 @default.
- W4312076051 hasConcept C71924100 @default.
- W4312076051 hasConcept C86178769 @default.
- W4312076051 hasConcept C98274493 @default.
- W4312076051 hasConceptScore W4312076051C147789679 @default.
- W4312076051 hasConceptScore W4312076051C155574463 @default.
- W4312076051 hasConceptScore W4312076051C171250308 @default.
- W4312076051 hasConceptScore W4312076051C178790620 @default.
- W4312076051 hasConceptScore W4312076051C181389837 @default.
- W4312076051 hasConceptScore W4312076051C185592680 @default.
- W4312076051 hasConceptScore W4312076051C187530423 @default.
- W4312076051 hasConceptScore W4312076051C192562407 @default.
- W4312076051 hasConceptScore W4312076051C2777628954 @default.
- W4312076051 hasConceptScore W4312076051C2777849778 @default.
- W4312076051 hasConceptScore W4312076051C2779820397 @default.
- W4312076051 hasConceptScore W4312076051C2780890252 @default.
- W4312076051 hasConceptScore W4312076051C49059817 @default.
- W4312076051 hasConceptScore W4312076051C55493867 @default.
- W4312076051 hasConceptScore W4312076051C56052488 @default.
- W4312076051 hasConceptScore W4312076051C71924100 @default.
- W4312076051 hasConceptScore W4312076051C86178769 @default.
- W4312076051 hasConceptScore W4312076051C98274493 @default.
- W4312076051 hasIssue "1" @default.
- W4312076051 hasLocation W43120760511 @default.
- W4312076051 hasOpenAccess W4312076051 @default.
- W4312076051 hasPrimaryLocation W43120760511 @default.
- W4312076051 hasRelatedWork W1579043743 @default.
- W4312076051 hasRelatedWork W2003528772 @default.
- W4312076051 hasRelatedWork W2025767241 @default.
- W4312076051 hasRelatedWork W2081849012 @default.
- W4312076051 hasRelatedWork W2187465520 @default.
- W4312076051 hasRelatedWork W2314489661 @default.
- W4312076051 hasRelatedWork W2355396268 @default.
- W4312076051 hasRelatedWork W2412874494 @default.
- W4312076051 hasRelatedWork W4293099295 @default.
- W4312076051 hasRelatedWork W4321374563 @default.
- W4312076051 hasVolume "13" @default.
- W4312076051 isParatext "false" @default.
- W4312076051 isRetracted "false" @default.
- W4312076051 workType "article" @default.